EnBiotix to Collaborate with Mayo Clinic on Engineered Phage Program
Startup targets HIV drug resistance in developing countries
Elanco, EnBiotix Establish Collaboration Exploring Engineered Phage Technology
Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Patients with Relapsed/Refractory B-cell Lymphoma
Dutch company to hold human clinical trial to reverse hearing loss
Vedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia
Pinteon Therapeutics $12.03 million Fundraising
Vedanta Biosciences Granted Third U.S. Patent Covering Methods Of Treating Infectious And Allergic Diseases With Bacterial Consortia
Subscribe to Gene Silencing/Gene Editing Horizon Discovery, Fulcrum Therapeutics Collaborate on Target Discovery Using CRISPR Screens
Vedanta Biosciences Granted Third U.S. Patent Covering Methods Of Treating Infectious And Allergic Diseases With Bacterial Consortia
